Ceva has already developed a healthy market share of the poultry health business, with the expectation of being number one in vaccines by the end of next year. “Our plan moving into the swine business is to have the same sort of success,” said Craig Wallace, CEO and North American | Pacific Zone Director. 

Click here to learn more about the global company which has experienced a five-fold growth increase since its founding in 2005.